Blackhawk Growth (BLRZ.F) 주식 개요블랙호크 그로스 코퍼레이션은 공개 소유의 투자 관리 회사입니다. 자세히 보기BLRZ.F 펀더멘털 분석스노우플레이크 점수가치 평가1/6미래 성장0/6과거 실적2/6재무 건전성0/6배당0/6강점주가수익률(4.2x)이 US 시장(19x)보다 낮습니다.올해부터 흑자전환위험 분석의미 있는 시가총액이 없습니다($226K)주식은 유동성이 매우 낮습니다마이너스 주주 지분수익이 USD$1m 미만입니다(CA$0)+ 위험 2건 추가모든 위험 점검 보기BLRZ.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.011해당 없음내재 할인율Est. Revenue$PastFuture-20m2m2016201920222025202620282031Revenue CA$0.4Earnings CA$0AdvancedSet Fair ValueView all narrativesBlackhawk Growth Corp. 경쟁사Aimfinity Investment ISymbol: OTCPK:AIMU.FMarket cap: US$6.9mWinmillSymbol: OTCPK:WNML.AMarket cap: US$7.3mBaker Global Asset ManagementSymbol: OTCPK:BAKRMarket cap: US$13.7mHorizon Group PropertiesSymbol: OTCPK:HGPIMarket cap: US$22.4m가격 이력 및 성과Blackhawk Growth 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.01152주 최고가CA$0.01152주 최저가CA$0.011베타1.111개월 변동0%3개월 변동n/a1년 변동n/a3년 변동n/a5년 변동-99.72%IPO 이후 변동-99.90%최근 뉴스 및 업데이트공시 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.공시 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.공시 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.공시 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.공시 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.공시 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.더 많은 업데이트 보기Recent updates공시 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.공시 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.공시 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.공시 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.공시 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.공시 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.주주 수익률BLRZ.FUS Capital MarketsUS 시장7D0%-5.8%0.3%1Yn/a-0.7%19.9%전체 주주 수익률 보기수익률 대 산업: BLRZ.F의 US Capital Markets 산업 대비 성과를 판단하기에 데이터가 부족합니다.수익률 대 시장: BLRZ.F의 US 시장 대비 성과를 판단하기에 데이터가 부족합니다.주가 변동성Is BLRZ.F's price volatile compared to industry and market?BLRZ.F volatilityBLRZ.F Average Weekly Movementn/aCapital Markets Industry Average Movement3.8%Market Average Movement7.3%10% most volatile stocks in US Market16.8%10% least volatile stocks in US Market3.1%안정적인 주가: BLRZ.F의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine BLRZ.F의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aJustin Hankawww.blackhawkgrowth.com블랙호크 그로스 코퍼레이션은 공개 소유의 투자 운용사입니다. 북미 전역의 주식 및 채권 시장에 투자합니다. 캐나다와 미국 모두에서 대마초 및 CBD 산업에 집중적으로 투자하고 있습니다.더 보기Blackhawk Growth Corp. 기초 지표 요약Blackhawk Growth의 순이익과 매출은 시가총액과 어떻게 비교됩니까?BLRZ.F 기초 통계시가총액US$225.51k순이익 (TTM)US$53.06k매출 (TTM)n/a4.2x주가수익비율(P/E)0.0x주가매출비율(P/S)BLRZ.F는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표BLRZ.F 손익계산서 (TTM)매출CA$0매출원가CA$0총이익CA$0기타 비용-CA$72.68k순이익CA$72.68k최근 보고된 실적Sep 30, 2025다음 실적 발표일해당 없음주당순이익(EPS)0.0082총이익률0.00%순이익률0.00%부채/자본 비율-79.9%BLRZ.F의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/01/26 00:25종가2025/10/29 00:00수익2025/09/30연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Blackhawk Growth Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.
공시 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.
공시 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.
공시 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.
공시 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.
공시 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.
공시 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.
공시 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.
공시 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.
공시 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.
공시 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.
공시 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.
